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Abstract 
Objectives: Two common types of orofacial pains that are clinically important to distinguish 
are odontogenic pain and temporomandibular disorders (TMD) pain. The aim of this study was 
to determine the sensitivity and specificity of two screening instruments in distinguishing 
patients with odontogenic pain from patients with TMD pain. 
Methods: A convenience sample of patients seeking care at an Endodontist’s office and at an 
Orofacial Pain Clinic was recruited. The 14-item Dental Pain Questionnaire (DePaQ) (Pau et 
al., 2005) was used to screen for odontogenic pain and the 6-item TMD-screener (Gonzalez et 
al., 2011) was used to screen for TMD pain. Sensitivity and specificity calculations, with 95% 
confidence intervals, were performed for both instruments. 
Results: Thirty-four patients with odontogenic pain and 37 patients with TMD pain were 
enrolled. Both groups had comparable age distribution (49±12 vs. 45±18 years) and gender 
composition (53% vs. 86% females). Results of the sensitivity and specificity are provided in 
the table below with determination of diagnostic accuracy of these measures evaluated using 
published guidelines. 
   
Odontogenic Pain versus TMD Pain 
(95% confidence interval)  
DePaQ  
Sensitivity  85% (69% to 95%)  
Specificity  11% (3% to 25%)  
TMD-screener  
Sensitivity  92% (78% to 98%)  
Specificity  59% (41% to 75%)  
Conclusion: The point estimates for both the DePaQ and TMD screener were “acceptable” in 
identifying patients who had the pain condition in question (i.e., sensitivity), although the point 
estimate for appropriately identifying patients who did not have the pain condition when they 
did not have it (i.e., specificity) was “non-acceptable” neither for the DePaQ nor for the TMD 
screener. The potential for high amounts of false positive responses with the DePaQ limits its 
use as a screening instrument when patients are suspected as having TMD pain. 
 v 
Table of Contents 
Acknowledgements ........................................................................................................ i 
Dedication .................................................................................................................... iii 
Abstract ........................................................................................................................ iv 
Table of Contents .......................................................................................................... v 
List of Tables .............................................................................................................. vii 
List of Figures ............................................................................................................ viii 
Introduction ................................................................................................................... 1 
Aim ............................................................................................................................... 7 
Methods ......................................................................................................................... 8 
Participants ................................................................................................................ 8 
Enrollment criteria .................................................................................................... 9 
Inclusion Criteria .................................................................................................. 9 
Exclusion Criteria: ................................................................................................ 9 
Sample Size ............................................................................................................. 10 
Screening questionnaires used ................................................................................ 11 
Dental pain screening questionnaire ................................................................... 11 
TMD screening questionnaire ............................................................................. 12 
Statistical analyses .................................................................................................. 12 
Results ......................................................................................................................... 15 
Description of patients ............................................................................................ 15 
Analysis of the DePaQ Screener ............................................................................. 16 
Analysis of the TMD Screener ............................................................................... 17 
Discussion ................................................................................................................... 18 
Participants’ enrollment: ......................................................................................... 19 
 vi 
Questionnaires: ....................................................................................................... 19 
Item analysis ........................................................................................................... 21 
Limitations: ............................................................................................................. 23 
Future studies .......................................................................................................... 24 
Conclusion .................................................................................................................. 24 
References ................................................................................................................... 26 
Tables .......................................................................................................................... 31 
Figures ......................................................................................................................... 42 
Appendix 1: Dental Pain Questionnaire ...................................................................... A 
Appendix 2: TMD screener ......................................................................................... D 
 vii 
List of Tables 
Table 1: Pulpal and apical diagnostic terminology ................................................. 31 
Table 2: Non odontogenic tooth pain ...................................................................... 32 
Table 3: Patterns of pain referral to teeth and associated regions ........................... 33 
Table 4: Diagnostic criteria for the patients recruited ............................................. 34 
Table 5: Characteristics of the 71 patients enrolled in the study ............................ 36 
Table 6: AIM 1.0: DePaQ: Odontogenic pain versus all TMD pain ...................... 37 
Table 7: AIM 1.1: DePaQ: Odontogenic pain versus TMD pain not referring to teeth 
only ............................................................................................................................... 37 
Table 8: AIM 1.2: DePaQ: Odontogenic pain versus TMD pain referring to teeth 
only ............................................................................................................................... 38 
Table 9: AIM 2.0: TMD Screener: All TMD pain versus Odontogenic pain ......... 38 
Table 10: AIM 2.1: TMD Screener: TMD pain not referring to teeth only versus 
Odontogenic pain .......................................................................................................... 39 
Table 11: AIM 2.2: TMD Screener: TMD pain referring to teeth only versus 
Odontogenic pain .......................................................................................................... 39 
Table 12: Comparison of the sample with other populations ................................. 40 
Table 13: DePaQ and TMD screener item analysis ................................................ 41 
  
 viii 
List of Figures 
Figure 1: Patients enrolled ...................................................................................... 42 
 1 
Introduction 
Pain related to a tooth and associated structures, referred to as odontogenic pain, is 
known to arise from inflammation within the dental pulp and/or periapical tissues. Such 
inflammation is related to disease within these tissues, usually bacterial, and is thought to 
be the main etiological factor related to the symptom of pain arising from these tissues1. 
The diagnoses of pulpal and periapical disease, as suggested by the American Association 
of Endodontists (AAE), are based on the signs and symptoms related to the tooth in 
question as reported by the patient2. These diagnoses and their criteria are presented in 
Table 1. 
In a prevalence study in the United States, within a sample of 45,711 households in the 
civilian population, 12% reported having had “toothache” over the last 6 months when 
asking them about five different types of orofacial pains3. Therefore, odontogenic pain is 
the most common orofacial pain and the most common reason for patients to seek dental 
care4, 5. Root canal treatment (RCT) is a common effective treatment for odontogenic pain 
and pathosis6, 7, 8. Hence the reason why odontogenic pain and RCT are of great interest to 
dentists and patients alike8-12.  
From all the diagnoses for odontogenic pain (Table 1), of which some are always 
associated with pain and some are not. Those associated with pain are: symptomatic 
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irreversible pulpitis as pulpal diagnosis; and symptomatic apical periodontitis and acute 
apical abscess as apical diagnoses.  
Jaw joint and/or face and cheek pain was also a common pain condition in the 
prevalence study for orofacial pains in the United States3, with prevalence of 6%. These 
conditions include TMD-related pain. TMDs are disorders related to the 
temporomandibular joint and masticatory muscles. TMDs can be classified into two 
subgroups; those that are associated with pain are: myalgia (muscle pain), myofascial pain 
(muscle pain with referral to other structures beyond the boundaries of the muscle 
palpated), and arthralgia (joint pain). It is important to know that having one diagnosis does 
not exclude having one or more of the others13. 
In a systematic review of population-based epidemiological studies of orofacial pain, 
it was observed that the median prevalence of orofacial pain in the general population is 
13%14. In the prevalence study for orofacial pains in the United States, it was indicated that 
some of the respondents could present with more than one type of pain; therefore a person 
that was complaining of “toothache” could be complaining about face pain too. This raises 
the question about the accuracy of self-reported orofacial pains because data suggests that 
patients may not easily separate different orofacial pains based on location of that pain15. 
Also, TMD is known to be perceived as “toothache”16 and odontogenic pain is known to 
contribute to TMD17. Diagnosing the etiology of odontogenic pain is usually fairly 
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straightforward, but on occasion can be challenging when signs and symptoms of pain are 
unclear or similar to other orofacial pain disorders that have a non-odontogenic origin.  
A thorough exam to rule out the diseases that can provoke pain with a non-odontogenic 
origin should be performed if all the tests for dental pathosis are negative. Table 2 lists all 
these conditions, their characteristics and diagnostic tests required. When a condition is 
misdiagnosed with other, there is a risk of unnecessary treatment18. A recognized reason 
for such a misdiagnosis is when pain is referred. Referred pain can be defined as pain felt 
in a part of the body different from that in which it originates19. In the head and neck, 
referred pain is prevalent and always merits consideration when forming a differential 
diagnosis16. Equally, TMDs, presenting at different source (origin of the pain) can cause 
pain at a distant site (location where the pain is felt)16. 
It is not completely known how odontogenic pain and TMD-related pain are associated, 
but a correlation has been noted, although there are a few studies comparing the two of 
them. One possibility could be the length of the intervention in the dental office: the longer 
the appointment and operating time, the more prone to develop TMD20, there are also cases 
of pulpalgias that can contribute to TMD-like pain17.  
Myofascial pain can refer pain to many structures, distant from the muscles palpated. 
The points in the muscle that can trigger the referred pain are called trigger points, and they 
are commonly found in skeletal muscles. Trigger points are localized, firm, hyperirritable 
nodules that patients often describe as “knots” within their muscles21. Muscles of the head 
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and neck area can refer their pain to the surrounding areas, and a possible site of pain, 
although not the most common16 is the teeth. Table 3 lists the sources and frequencies of 
pain referral to teeth in a study where firm pressure was applied for approximately five 
seconds to trigger points, nodules of spot tenderness, and selected masticatory structures 
within the head and neck region on 230 patients with TMD16.  
One of the possible reasons for this ambiguous pain is of its location. It has been 
demonstrated that when pain is felt in areas of the face that are in close geographical 
proximity, such as within the TMJ and ipsilateral masseter muscle, patients have 
difficulties in discriminating between possible sources15. This suggests that discrimination 
between ipsilateral teeth and masticatory muscles may also be difficult. 
A clinical evaluation with imaging by an expert practitioner remains as the gold 
standard for the identification of tooth pathosis and of TMD. This is a time-consuming and 
costly approach to deriving diagnoses for epidemiological studies, so the development and 
validation of question-based screening instruments are desirable. An accurate screening 
instrument should have high sensitivity and specificity.  Sensitivity is the ability for the 
instrument to identify patients who have the disease when they have it. Specificity is the 
ability of an instrument to identify patients who do not have the disease when they do not 
have it. Screening tests that have high sensitivity and specificity, meaning they possess the 
ability to very accurately categorize patients by diagnostic status have a good 
discriminative value. Such a property is usually best achieved with multiple questions, but 
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this can make the screening questionnaire long and cumbersome to administer. Therefore, 
there is usually a balance between ease of implementation of a screening questionnaire and 
its ability to correctly categorize patients when constructing a screening questionnaire.  
In regards to questionnaires focusing on screening for painful tooth-related disease, 
there are few studies that have been published. They are listed below:  
- McGill Pain Questionnaire: screens for pulpitis and pericoronitis22, 
- McGill Pain Questionnaire: screens for irreversible and reversible pulpitis23, 
- McGill-Melzack Pain Questionnaire: screens for pulpal, periodontal and 
temporomandibular joint pain24, and  
- Dental Pain Screening Questionnaire (DePaQ): screens for acute periapical 
periodontitis, irreversible pulpitis, reversible pulpitis, dentine hypersensitivity and 
pericoronitis25. 
For those screening questions, the one with the greatest discriminating ability is the 
DePaQ, which demonstrated good sensitivity and specificity and, therefore, was our 
instrument of choice. More characteristics of this questionnaire will be described within 
the Methods section below. 
In regards of TMD questionnaires, eight studies have been published, but only one of 
them used the Standards for Reporting of Diagnostic Accuracy-recommended parameters 
of assessment: operationalized criteria, examiners using a calibrated technique and 
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consensus diagnosis26, and discriminated between pain-related TMD and mechanical 
symptoms associated with the temporomandibular joint (TMJ). This instrument is the TMD 
related-pain screener27 which was used in this research and will be described in details in 
the Methods section below. 
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Aim 
The primary aim of this study was to determine the sensitivity and specificity of two 
screening questionnaires, one designed for odontogenic pain (DePaQ) and one for TMD 
pain (TMD screener), in a group of patients experiencing pain of either odontogenic or 
TMD origin. The secondary aims of this study were to explore how the screening questions 
perform in subsets of patients, such as TMD pain referred to the dentoalveolar region and 
presenting as “tooth pain”, to assess whether limitations at the group level may be driven 
by responses from subsets of patients. 
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Methods 
This study is derived from data collected within a parent study designed to explore item 
selection for the development of a Persistent Dentoalveolar Pain disorder (PDAP) 
screening questionnaire. Required ethics approval from the University of Minnesota 
Institutional Review Board regulations and informed consent for all human subjects was 
obtained before the initiation of the study protocol. 
Participants 
Recruitments of patients were performed by board certified Orofacial Pain practitioners 
and a board certified Endodontist. TMD pain patients were recruited from the TMD and 
Orofacial Pain Clinic in the School of Dentistry at the University of Minnesota, 
Minneapolis, Minnesota. Odontogenic pain patients were recruited in a private endodontic 
practice, The Dental Specialists, within the Twin Cities area. A convenience sample of 
these two groups of patients was collected. Patients presenting with both diagnoses were 
excluded for being in this study because the report of the symptom of pain could not be 
attributed to only one diagnosis and thereby making the response ambiguous. Some 
patients with TMD pain perceived their pain in the jaw and face, while others perceived 
their pain in a tooth / alveolus, as referred from other structures. These differences in the 
two subgroups will be covered in greater detail below. 
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Enrollment criteria 
The following criteria were used to select patients for this study. 
Inclusion Criteria 
Odontogenic pain sample: Patients diagnosed with symptomatic irreversible pulpitis, 
symptomatic apical periodontitis and/or symptomatic apical abscess following the 
diagnostic criteria28 (Table 4). 
TMD pain sample: Patients with diagnosis of TMD pain, including myalgia, myofascial 
pain with referral or arthralgia following the diagnostic criteria for TMD (DC/TMD)13 
(Table 4). Among the TMD sample, patients presenting with referred pain to surrounding 
areas, as it is described in myofascial pain with referral, were accepted. There were made 
two subgroups of patients in this group, depending on the presentation of the pain, if the 
site where it was referred was the dentoalveolar region, as it was described by Wright16, or 
not, which was specifically measured due to the increased potential for diagnostic 
confusion. 
 Patients seeking treatment for their painful condition in one of the clinics of the study. 
 Age, 18 years old and older.  
 Comfortable communicating in English. 
Exclusion Criteria: 
 Patients with another comorbid orofacial pain diagnosis. 
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 Patients with a history of traumatic injuries to the orofacial region. 
 Patients with a major systemic illness related to altered pain sensitivity, or with 
fibromyalgia and other widespread bodily pain conditions. 
 Patients with a history of TMJ surgery or inter-articular steroid injection. 
 Unable to give informed consent. 
 Previously enrolled in this study. 
Sample Size 
The number of patients per pain group was calculated to be 20 per group, this was based 
on the needs for the parent study.  Over enrollment of patients in both groups was to address 
a different research question, as well as to account for missing data. 
  
 11 
Screening questionnaires used 
Dental pain screening questionnaire 
The Dental Pain Questionnaire (DePaQ) was used as the instrument to detect patients 
with odontogenic pain25. It is a 14 item questionnaire developed in the United Kingdom, 
designed to differentiate three groups of odontogenic tooth pain:  
 Group A: Acute periapical periodontitis and irreversible pulpitis, 
 Group B: Reversible pulpitis and dentine hypersensitivity  
 Group C: Pericoronitis. 
The item generation study of this questionnaire was developed within a sample of 313 
patients, where just over 50% were male. The sample consisted of Group A patients-35%, 
Group B-32%, and Group C-18%. Questionnaire items were generated through literature 
review and individual interview of all the subjects. Later on, a validation study of the 
questionnaire was performed within another group of 161 subjects, 60% of who were male. 
The sample consisted of 73% Group A subjects, 13% Group B and 14% Group C. The 
sensitivity (95% CI) was 80% (71 to 87%) for Group A, 85% (62 to 97%) for Group B and 
59% (36 to 80%) for Group C; specificity was 83% (69 to 93%), 89% (83 to 94%) and 
90% (84 to 95%) respectively. This questionnaire was recently validated in a different 
population29 in South India resulting in sensitivity values of 85% (77 to 91%), 82% (65 to 
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93) and 79% (49 to 95%) for group A, B and C respectively. Specificity values were 75% 
(62 to 86%), 90% (83 to 94%) and 95% (91 to 98%) for group A, B and C respectively. 
TMD screening questionnaire 
The TMD screener was developed as a self-report instrument in screening patients for 
pain-related TMD27. It was designed in a short (three-item) and long (six-item) versions 
using psychometric methods for item selection, and evaluated for validity among 504 
participants. It was compared pain-related TMD versus healthy controls; versus non-
painful TMD; and versus headaches. Among the results, in all the groups and both 
questionnaires, the sensitivity was 99%, where specificity was slightly higher (97%) in the 
long version, while in the short version was at least 95%. In our study, we opted for the 
long version, because it had better specificity scores. 
Statistical analyses 
Data were managed using the spreadsheet software Microsoft Excel (Microsoft Excel 
2010 for PC: Microsoft Corporation) and all analyses were performed using the statistical 
software package STATA (Stata Statistical Software: V12 for Mac. College Station, TX: 
StataCorp LP). 
The data were analyzed comparing all patients with known odontogenic pain with all 
patients with known TMD pain group using the two questionnaires. This was contrasted 
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using two by two tables. Four subgroup analyses were performed, depending on the site 
where the pain was felt. The analyses were as follows: 
 Aim 1.0. Determine the sensitivity and specificity of the DePaQ for identifying all 
patients with odontogenic pain versus all patients with TMD pain as controls 
- Subaim 1.1. Determine the sensitivity and specificity of the DePaQ for 
identifying all patients with odontogenic pain versus patients with TMD pain, 
excluding TMD pain referred to teeth as controls. 
- Subaim 1.2. Determine the sensitivity and specificity of the DePaQ for 
identifying all patients with odontogenic pain versus patients with TMD pain 
referred to teeth only as controls.  
 Aim 2.0. Determine the sensitivity and specificity of the TMD screening 
questionnaire for identifying all patients with TMD pain versus odontogenic pain 
patients as controls. 
- Subaim 2.1. Determine the sensitivity and specificity of the TMD screening 
questionnaire for identifying patients with TMD pain, excluding TMD pain 
referred to teeth, versus odontogenic pain patients as controls. 
- Subaim 2.2. Determine the sensitivity and specificity of the TMD screening 
questionnaire for identifying patients with TMD pain referred to teeth only 
versus odontogenic pain patients as controls. 
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Results are presented as point-estimates for the sensitivity and specificity of the 
questionnaires for each comparison with 95% confidence intervals presented to 
demonstrate the level of precision these calculations offer.  
Levels of diagnostic accuracy were measured using sensitivity and specificity estimates 
described by Dworkin and LeResche (acceptable sensitivity=70% and acceptable 
specificity=95%)30. 
 15 
Results 
This study reports on data collected through 33 months, between October 2011 and 
July 2014, which was the duration of data collection. 
Description of patients  
A total of 82 patients participated in this study but 11 of them were excluded:  
- 5 patients (4 diagnosed with TMD pain and 1 with odontogenic pain) were 
excluded because they left more than 10% of one of the questionnaires 
unanswered, that means two or more questions in the DePaQ or one or more 
questions in the TMD screener (4 of them left question number 13 in DePaQ 
questionnaire unanswered or not completely answered, which is related to the 
quality of the pain, and it is composed by 4 subquestions; and one left 
unanswered question number 2 of the TMD screener, about having pain upon 
awakening) and  
- 6 odontogenic pain patients had concomitant TMD pain.  
From the 71 patients included, 34 (47%) of them had odontogenic pain, [15% (5) with 
symptomatic irreversible pulpitis only, 50% (17) with symptomatic apical periodontitis 
only, 18% (6) with acute apical abscess, and 18% (6) with symptomatic irreversible 
pulpitis and symptomatic apical periodontitis. From those with a painful pulpal 
diagnosis only, the apical was asymptomatic because of having it normal]. Among the 
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TMD pain group [46% (17) with myofascial pain, 5% (2) with arthralgia, and 49% (18) 
with myofascial pain and concomitant arthralgia], there was a subdivision could be 
made for a secondary study, where 32% (12) of the patients, reported their pain being 
perceived in their teeth so their clinical chief complaint was “toothache” (Figure 1). 
The demographics of the patients enrolled are presented in Table 5. 
Analysis of the DePaQ Screener 
Using the DePaQ as the screening instrument, to discriminate between odontogenic 
pain group versus the whole TMD pain group, the sensitivity obtained was 85% (95% CI= 
69% to 95%), and the specificity was at 11% (95% CI: 3% to 25%). Positive predictive 
value was 47% (95% CI: 34% to 60%). Negative predictive value was 44% (95% CI: 14% 
to 79%). Table 6 demonstrate further details. 
When the TMD pain sample was divided in the two subgroups depending on if TMD 
pain was referred to teeth or not, the difference was negligible; when comparing 
odontogenic pain versus TMD pain not referring to teeth only, sensitivity and specificity 
were 85% (95% CI: 69% to 95%) and 12% (95% CI: 3% to 31%) respectively, positive 
predictive value was 57% (95% CI: 42% to 71%) and negative predictive value was 37% 
(95% CI: 9% to 75%) (Table 7), when comparing odontogenic pain versus TMD pain 
referring to teeth only, sensitivity and specificity were 85% (95% CI: 69% to 95%) and 8% 
(95% CI: 0.2% to 38%) respectively, positive predictive value was 72% (95% CI: 56% to 
85%) and negative predictive value was 17% (95% CI: 0.4% to 64%) (Table 8). 
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Analysis of the TMD Screener 
When the TMD screener was the questionnaire used to compare the odontogenic pain 
group versus the whole TMD pain group, it showed a sensitivity of 92% (95% CI: 78% to 
98%), and specificity of 59% (95% CI: 41% to 75%). Positive predictive value was 71% 
(95% CI: 56% to 83%). Negative predictive value was 87% (95% CI: 66% to 97%) Table 
9 demonstrate further details. 
When the TMD pain sample was divided in the two subgroups depending on if TMD 
pain was referred to teeth or not, the difference was negligible; when comparing 
odontogenic pain versus TMD pain not referring to teeth only, sensitivity and specificity 
were 92% (95% CI: 74% to 99%) and 59% (95% CI: 41% to 75%) respectively, positive 
predictive value was 62% (95% CI: 45% to 77%) and negative predictive value was 91% 
(95% CI: 71% to 99%) (Table 10); when comparing odontogenic pain versus TMD pain 
referring to teeth only, sensitivity and specificity were 92% (95% CI: 61% to 100%) and 
59% (95% CI: 41% to 75%) respectively, positive predictive value was 44% (95% CI: 24% 
to 65%) and negative predictive value was 95% (95% CI: 76% to 100%) (Table 11). 
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Discussion 
The purpose of this study was to test the ability of whether one of two screening 
questionnaires, one used to identify odontogenic pain and one used to identify TMD pain, 
can adequately separate patients with these orofacial pain conditions. The results indicate 
that both questionnaires, the DePaQ and the TMD screener, have an acceptable sensitivity 
whilst the specificity is unacceptable for both screening questionnaires. This means that 
DePaQ will identify those patients that have odontogenic pain most of the time, 85%, when 
they have odontogenic pain and the TMD screener will identify those patients that have 
TMD pain most of the time, 92%. Nevertheless the questionnaires perform less well in 
identifying patients as not having the disorder when they do not have it. The DePaQ, with 
a specificity of 11% will classify 89% of the patients with TMD as patients having 
odontogenic pain. Such poor performance limits this questionnaire’s use in populations 
with both TMD pain and/or odontogenic pain. The TMD screener, with a specificity of 
59%, will classify 41% of the patients with odontogenic pain as having TMD pain. 
Furthermore, the TMD screener and the DePaQ do not seem to be influenced by the site of 
pain because subset analyses yielded very similar sensitivity and specificity results when 
patients with TMD pain perceived to be of tooth origin only (Table 8 and Table 11) were 
compared to TMD pain patients perceived to be in the jaw (Table 7 and Table 10). This is 
encouraging because TMD pain patients do not seem to distinguish between different 
locations of their TMD pain15 and dentists have been reported to misinterpret TMD pain 
perceived as “tooth” pain as being odontogenic in origin31. 
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Participants’ enrollment: 
To compare our enrolled patients with those enrolled in the development studies for 
each questionnaire used is difficult because of the minimal description of the population in 
the relevant articles, but we can compare our patients with notable studies that describe the 
typical patient with odontogenic pain, such as Nixdorf study designed to measure pain 
associated with initial orthograde root canal treatment32, and TMD pain, such as Schiffman 
study about the research diagnostic criteria for TMD33, performed in similar locations as 
our study. Comparing the odontogenic pain group with Nixdorf´s study and the TMD pain 
group with the painful TMD group that went to the clinic seeking for care in Schiffman´s 
study, there is a high similarity, despite the lower number of patients in our sample, in all 
the characteristics except the level of education which is slightly lower in our study. In 
Table 12 are depicted the comparisons of each characteristic. This similitude means that 
the patients in our study were correctly selected as typical patients in each group, and likely 
our data relate to typical cases. 
Questionnaires: 
The DePaQ demonstrated sensitivity as acceptable as it presented in the development 
and validation studies, with the 85% value it scored even higher than in the development 
study. On the other hand, specificity results in our study showed an unacceptable 
specificity, 11%, completely different than the development study where they found a score 
of 83%. The DePaQ is widely recommended as a screening test for odontogenic pain. 
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However, the assessment of referred pain from other sources felt in the teeth was neglected 
when the questionnaire was developed. In fact, previous studies only compared different 
types of tooth pain, and did not compare these to other pains in the face/head that could 
confuse patient and practitioner when describing/giving a diagnosis.  
The DePaQ was developed to classify patients into three different groups, depending 
on their condition, facilitating in this way the assessment of dental treatment needs. It has 
been seen in this study that there was a high probability of false positive results, in case of 
a non odontogenic origin of the pain, resulting in a risk of mistreatment. 
The use of the DePaQ as a screening instrument for patients complaining of 
“toothache” can cause confusion to patient and practitioner when it scores positive for 
odontogenic pain and it is not the real cause of the pain. Given the low specificity score, 
this questionnaire is not recommended to differentiate between odontogenic pain and TMD 
pain. 
The TMD screener scored 92% in sensitivity, even though it was 7 points less than in 
the development and validation study, it is still acceptable and expected because the score 
will always decrease if the questionnaire is primarily tested in the same type of population 
as where it was developed, which is the case with the TMD screener. The TMD screener 
has shown to be a good instrument when comparing TMD pain to other conditions, such 
as healthy patients, non-painful TMDs or headaches. During the development of the TMD 
screener, odontalgia patients were included; however, due to logistic restrictions in data 
 21 
collection, TMD was not assessed in this group and, as a result, these data were not 
analyzed. To improve the specificity score for this questionnaire, and increase its accuracy 
level, it is recommendable changing something in the questionnaire to improve the 
screening to separate TMD pain from odontogenic pain. 
Item analysis 
An item analysis is needed to study how the TMD screener works, where does it fail 
separating the odontogenic pain patients from the TMD pain patients (giving a score very 
similar to the TMD pain patients and to the odontogenic pain patients) and where does it 
help. And it is also needed for the DePaQ to see if there is any question in this questionnaire 
that could help in the screening, separating the odontogenic pain group from the TMD pain 
group. 
In Table 13 there are included the mean answers to the DePaQ and to the TMD screener 
for each item, and also Fischer’s coefficients for each question for a positive result for 
odontogenic pain in the DePaQ. Appendix 1 and 2 include the questions of the DePaQ and 
the TMD screener. 
The results of the item analysis are relevant in three questions: 
1. Question number 2 in the DePaQ about duration of the pain: it is the only question 
in this questionnaire that actually differentiates between odontogenic pain and 
TMD pain, giving a mean (SD) result of 2.3 (1) for odontogenic pain and 4.2 (0.9) 
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or 4.2 (1.1) for TMD pain not referring or referring to teeth respectively. This means 
that the way this question is formulated helps to separate the two different pains: 
odontogenic pain from TMD pain. This question separates the duration between 
less than a week, 1 to 4 weeks, 4 weeks to 6 months, 6 months to a year and a year 
or longer. Moreover, if we look at this question only, the results say that 56% (21) 
of the TMD patients had the pain for a year or longer, whilst the odontogenic pain 
was suffered for shorter periods of time, between less than a week 23% (8), or 1 to 
4 weeks 44% (15). 
2. Question number 1 in the TMD screener about the duration of the pain: the results 
for the three groups are very close, the mean scores (SD) are 1.1 (0.8), 1.4 (0.5) and 
1.3 (0.6) for odontogenic pain, TMD pain not referring to teeth, and TMD pain 
referring to teeth respectively. This shows that the wording of this question 
confuses the result. The TMD screener distinguishes in pain duration between no 
pain, from brief to more than a week but stopping, or continuous. The similar scores 
for the three groups indicate that this question should be changed for something 
more specific, like what it was seen in question number 2 of DePaQ. 
3. Question number 3 in the TMD screener about having pain when chewing hard and 
tough food: the results in this question help in the confusion between TMD and 
odontogenic pain, with a mean score of 0.8 (0.4), 1 (0.2) and 1 (0) for odontogenic 
pain, TMD pain not referring to teeth and TMD pain referring to teeth respectively. 
This indicates that all the groups have pain when chewing, and that odontogenic 
 23 
pain patients cannot differentiate between jaw and teeth, and they will answer as 
having pain in their jaw most of the times. 
The information that is given by the TMD screener is important, but it is not enough, 
because it can be confusing for differentiating TMD pain from odontogenic pain, like we 
can see in the item analysis, in the TMD screener in question number 1 about duration of 
pain and in question number 3 about chewing hard or tough foods. We may not need to 
increase the number of questions in this questionnaire, but to change the wording of these 
two questions. In question number 2 of DePaQ we can observe how it is possible to 
distinguish between odontogenic pain and TMD pain with a question about duration: TMD 
pain tends more to a longer period (between 6 months and a year) of pain while odontogenic 
pain tends to be a short term (between 1 and 4 weeks). 
Limitations: 
A limitation of this study is the sample size, because group sizes greater than 50 each 
are desired. Also, larger subgroups, such as TMD pain referred to teeth, would be helpful 
in adding confidence that what we observed is not a spurious finding due to the clinic 
setting from which these patients were recruited. Furthermore on this idea, having a third 
group that had both odontogenic pain and TMD pain would be helpful in elucidating how 
these screening questionnaires performed in the presence of comorbid pain conditions. 
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Another limitation is the patients included and resultant subgroup comparisons that 
could be assessed. Different subgroup comparisons, such as patients with anterior tooth 
pain verses posterior tooth pain, because it is conceivable that the TMD questionnaire 
performs worse with patients experiencing pain from mandibular lower third molars than 
from superior central incisors based on location of the pain. As well, being able to assess 
whether patients with primarily a pulpal diagnosis for their pain, such as symptomatic 
irreversible pulpitis, respond differently than patients with apical diagnoses for their pain, 
such as necrotic pulp and symptomatic apical periodontitis, would be helpful because these 
pains have different characteristics and can be perceived differently28. 
Future studies 
For future studies, it would be interesting to test the TMD screener once the change in 
the wording in those two problematic questions has occurred, to observe how it performs 
in separating odontogenic pain patients among the TMD pain patients. Also, it would be 
interesting to assess how this questionnaire would perform in patients having two comorbid 
orofacial pain conditions, such as those that were studied here as well as others, because 
that is how frequently patients present. 
Conclusion 
Both the DePaQ and the TMD screener have acceptable sensitivity, but unacceptable 
specificity. The extremely low result in the specificity in the DePaQ means that it is not 
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suitable for use for diagnostic purposes in populations that are known to have TMD pain 
because it will misdiagnose people with odontogenic pain, but it can be used in 
epidemiological studies designed to estimate prevalence rates of tooth pain, because it can 
be applied the error rates, which is known, to the results to calculate the misclassification. 
The TMD screener, because it has modest specificity and excellent sensitivity, has potential 
for use in distinguishing people with odontogenic pain from TMD pain for population-
based research and also for diagnostic purposes. Further research is needed to improve the 
specificity of the TMD screener, such as by adding additional questions that either 
positively identify or rule out odontogenic pain, to produce a questionnaire suitable for 
epidemiological research purposes. 
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Tables 
Table 1: Pulpal and apical diagnostic terminology2 
Pulpal diagnosis 
Chief 
complaint 
History 
Radiographic 
findings 
EPT 
Thermal 
testing 
Percussion 
Palpatio
n 
Mobility Other 
Normal Pulp None  Normal R R, NL     
Reversible pulpitis 
Hot &/or cold 
sensitivity 
 Normal R 
Exaggera
ted 
   
Caries, 
cracks, 
restorative 
procedures 
or trauma 
Symptomatic 
irreversible 
pulpitis 
Lingering hot 
&/or cold 
sensitivity 
Spontaneou
s pain 
Normal, widened 
PDL, or ARL 
R 
Exaggera
ted L 
   
Asymptomatic 
irreversible 
pulpitis 
None  
Normal, widened 
PDL, or ARL 
R R    
Necrotic pulp Variable Variable 
Normal, widened 
PDL, or ARL 
NR NR    
Previously treated Variable  
Normal, widened 
PDL, or ARL 
NR 
NR 
(Normall
y) 
   
Coronal 
microleaka
ge? 
Previously initiated 
therapy 
Variable  
Normal, widened 
PDL, or ARL 
NR 
NR 
(Normall
y) 
   
Coronal 
microleaka
ge? 
Apical diagnosis 
Chief 
complaint 
History 
Radiographic 
findings 
EPT 
Thermal 
testing 
Percussion 
Palpatio
n 
Mobility Other 
Normal Apical 
tissues 
None  Normal R R, NL NS NS 
Physiolo
gic 
 
Symptomatic 
apical periodontitis 
Discomfort 
when biting or 
chewing 
Recent 
restoration? 
Normal, widened 
PDL, or ARL 
R or 
NR 
R or NR S S or NS ± 
Occlusal 
trauma 
Asymptomatic 
apical periodontitis 
None 
Asymptom
atic 
ARL NR NR NS NS ± 
Necrotic or 
previously 
treated/Initi
ated 
Acute apical 
abscess 
Pain and 
swelling 
Coronal 
microleaka
ge? 
Normal, widened 
PDL, or ARL 
NR NR S (+++) 
S 
(variable) 
Variable 
Necrotic or 
previously 
treated/Initi
ated 
Chronic apical 
abscess 
Bad taste or 
“gum bump” 
Asymptom
atic 
ARL NR NR NS NS 
Generall
y 
Physiolo
gic 
Necrotic or 
pulpless 
with Sinus 
Tract 
Condensing osteitis 
Asymptomatic 
or variable 
pulpal 
symptoms 
Extensive 
restorative 
history/crac
k 
Increased 
radiodensity/Opac
ity 
R or 
NR 
Variable S or NS S or NS 
Generall
y 
Physiolo
gic 
Evidence 
of chronic 
inflammati
on 
Focal 
osteopetrosis/peria
pical osteosclerosis 
Asymptomatic 
Unrestored 
tooth or 
normal 
pulp 
Increased 
radiodensity/Opac
ity 
R R, NL NS NS 
Physiolo
gic 
Non-
restored 
tooth with 
normal 
findings 
EPT: Electric pulp tester, PDL: Periodontal ligament, ARL: Apical radiolucency, R: Response, NR: Non response, L: Linger NL: Not 
linger, , S: Sensitive, NS: Not sensitive 
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Table 2: Non odontogenic tooth pain18, 31, 32 
Types Condition Characteristics Investigations 
Musculoskeletal 
TMDs (From DC/TMD):  
–Myofascial pain  
–Arthralgia (pain but no 
DJD) 
 
Sinus and/or nasal 
mucosal origin 
 
Salivary gland pain 
Chronic dull ache 
following muscular 
distribution 
Muscular dysfunction 
Muscle tenderness 
Imaging normal 
Diagnostic block no effect 
Radiograph or CT may show bone 
morphology changes 
MRI may show disc abnormality 
Neurovascular 
Primary Headache 
Other Primary Headaches 
– Cluster Headache  
– Paroxysmal 
Hemicrania 
– Hemicrania Continua 
– SUNCT 
– Cough / Stabbing / 
Exertional / Hypnic HA 
Throbbing, usually 
unilateral, intermittent 
lasting 4-72 hours. 
Photophobia, 
phonophobia, nausea or 
vomits may be present 
Muscle palpation normal. 
Image normal 
Blood tests normal 
Neuropathic 
– Neuralgia (classic Tic 
Douloureux) 
– Neuritis 
– Neuroma 
– Neuropathy (idiopathic 
& deafferentation related 
pains) 
– Persistent dentoalveolar 
pain 
– Sympathetically 
mediated pain 
Burning, constant. 
Sharp shooting. 
Dull, constant or almost 
constant. 
Trigeminal nerve 
distribution 
Neuropathic pain is a diagnosis of 
exclusion: 
• Thorough dental exam & 
imaging 
• Brain MRI with contrast, to rule 
out an intracranial lesion and look 
for nerve root impingement, as 
well as elsewhere 
• Consider investigations of 
demyelinating disorders, such as 
MS (autoimmune) 
• Rule out osteomyelitis of the 
jaw – bone scan 
Pathological  
– Oral squamous cell 
carcinoma 
– Brain tumor 
Usually painless unless 
advanced 
Abnormal CT 
Psychogenic 
Abnormal often 
exaggerate description of 
symptoms 
Abnormal response to 
treatment 
 
Objective tests normal 
Subjective tests atypical 
Known previous psychiatric 
history and treatment 
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Table 3: Patterns of pain referral to teeth and associated regions 
(Adapted from Wright, 2000)16.  
Source of referred 
pain 
Site of perceived referred pain  
Frequency 
Maxillary 
molars 
Maxillary 
premolars 
Maxillary 
anterior 
teeth 
Mandibular 
molars 
Mandibular 
premolars 
Mandibular 
anterior 
teeth 
Temporalis muscle 3 3 2 1 1 1 
Temporomandibular 
joint 
2 1 1 2 0 0 
Masseter muscle 25 11 4 40 8 8 
Lateral pterygoid 
area 
6 6 2 1 2 2 
Medial pterygoid 
area 
0 0 2 0 0 0 
Coronoid process 0 0 0 1 0 0 
Sternocleidomastoid 
muscle 
0 0 0 1 1 1 
Anterior digastric 
muscle 
0 0 0 0 1 1 
Posterior digastric 
muscle 
0 0 0 1 0 0 
Of the 230 patients with pain referral, a total of 140 had referral to teeth regions and were included in this table. 
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Table 4: Diagnostic criteria for the patients recruited13, 28 
Group Diagnostic criteria 
Odontogenic pain 
group 
Symptomatic irreversible pulpitis 
- Lingering thermal pain, 
AND/OR 
- Spontaneous pain 
AND/OR 
- Referred pain. 
Symptomatic apical periodontitis 
- Painful response to biting and/or percussion or palpation. 
- It might or might not be associated with an apical radiolucent area 
 
Acute apical abscess 
- Rapid onset 
- Spontaneous pain 
- Tenderness of the tooth to pressure 
- Pus formation 
- Swelling of associated tissues 
TMD pain group 
Myalgia 
- Pain History: 
1. Pain in the face, jaw, temple, in front of the ear, or in the ear 
in the last 30 days. 
2. Pain changed with jaw movement, function or parafunction. 
PLUS 
- Pain Report on Examination: 
1. Palpation results in report of FAMILIAR pain (1 kilogram)  
a. Temporalis muscle: posterior, middle, and anterior, 
or 
b. Masseter muscle: origin, body, and insertion 
OR 
2. Opening movements results in FAMILIAR pain (temporalis 
or masseter muscles) 
a. Maximum unassisted, or 
b. Maximum assisted opening 
• Familiar pain is pain that is similar or like their pain complaint 
Myofascial pain with referral 
- Pain History: location of pain confirmed during exam 
Same as Myalgia 
AND 
- Pain Report on Examination: 
Same as Myalgia 
AND 
Report of pain with palpation at a site beyond the boundary of the 
muscle(s) being palpated. 
Arthralgia 
- Pain History: location of pain confirmed during exam 
1. Pain in the face, jaw, temple, in front of the ear, or in the ear 
in the last 30 days. 
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2. Pain changed with jaw movement, function or parafunction. 
PLUS 
- Pain Report on Examination: 
1. Palpation of any joint site results in FAMILIAR joint pain 
a. Lateral pole with fingertip applying  (0.5 kilogram), 
or 
b. Around the lateral pole (1 kilogram). 
OR 
2. Range of motion results in FAMILIAR joint pain  
a. Maximum unassisted opening, or  
b. Maximum assisted opening, or 
c. Lateral or protrusive movements 
d. Familiar pain is pain that is similar or like their pain 
complaint 
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Table 5: Characteristics of the 71 patients enrolled in the study 
 
Odontogenic 
pain 
n=34 
TMD pain 
n=37 
 Mean (SD) or % (n) 
Age in years 49 (12) 45 (18) 
Gender: female 53 (18) 86 (32) 
Ethnicity: non-Hispanic 100 (34) 97 (36) 
Race: white 79 (27) 92 (34) 
Income ≥ $30,000 85 (29) 43 (16) 
Dental insurance: yes 94 (32) 81 (30) 
Level of education: college degree or more 53 (18) 46 (17) 
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Table 6: AIM 1.0: DePaQ 
Odontogenic pain versus all TMD pain 
  
Odontogenic pain  
Gold standard 
 
  Odontogenic pain 
TMD pain 
(all) 
Total 
DePaQ 
Positive 29 33 62 
Negative 5 4 9 
 Total 34 37 71 
Point estimate  
(95% CI) 
Sensitivity= 85% (69% to 95%) 
Specificity= 11% (3% to 25%) 
Positive Predictive Value= 47% (34% to 60%) 
Negative Predictive Value= 44% (14% to 79%) 
 
Table 7: AIM 1.1: DePaQ 
Odontogenic pain versus TMD pain not referring to teeth only 
  
Odontogenic pain  
Gold standard 
 
  
Odontogenic 
pain 
TMD (not referring 
to teeth only) 
Total 
DePaQ 
Positive 29 22 51 
Negative 5 3 8 
 Total 34 25 59 
Point estimate  
(95% CI) 
Sensitivity= 85% (69% to 95%) 
Specificity= 12% (3% to 31%) 
Positive Predictive Value= 57% (42% to 71%) 
Negative Predictive Value= 37% (9% to 75%) 
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Table 8: AIM 1.2: DePaQ 
Odontogenic pain versus TMD pain referring to teeth only 
  
Odontogenic pain  
Gold standard 
 
  
Odontogenic 
pain 
TMD (referring to 
teeth only) 
Total 
DePaQ 
Positive 29 11 40 
Negative 5 1 6 
 Total 34 12 46 
Point estimate  
(95% CI) 
Sensitivity= 85% (69% to 95%) 
Specificity= 8% (0.2% to 38%) 
Positive Predictive Value= 72% (56% to 85%) 
Negative Predictive Value= 17% (0.4% to 64%) 
 
Table 9: AIM 2.0: TMD Screener 
All TMD pain versus Odontogenic pain  
  
TMD pain  
Gold standard 
 
  TMD (all) Odontogenic pain Total 
TMD Screener 
Positive 34 14 48 
Negative 3 20 23 
 Total 37 34 71 
Point estimate  
(95% CI) 
Sensitivity= 92% (78% to 98%) 
Specificity= 59% (41% to 75%) 
Positive Predictive Value= 71% (56% to 83%) 
Negative Predictive Value= 87% (66% to 97%) 
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Table 10: AIM 2.1: TMD Screener 
TMD pain not referring to teeth only versus Odontogenic pain  
  
TMD pain  
Gold standard 
 
  
TMD (Not referring 
to teeth only) 
Odontogenic 
pain 
Total 
TMD Screener 
Positive 23 14 37 
Negative 2 20 22 
 Total 25 34 59 
Point estimate  
(95% CI) 
Sensitivity= 92% (74% to 99%) 
Specificity= 59% (41% to 75%) 
Positive Predictive Value= 62% (45% to 77%) 
Negative Predictive Value= 91% (71% to 99%) 
 
Table 11: AIM 2.2: TMD Screener 
TMD pain referring to teeth only versus Odontogenic pain  
  
TMD pain  
Gold standard 
 
  
TMD (Referring to 
teeth only) 
Odontogenic 
pain 
Total 
TMD Screener 
Positive 11 14 25 
Negative 1 20 21 
 Total 12 34 46 
Point estimate  
(95% CI) 
Sensitivity= 92% (61% to 100%) 
Specificity= 59% (41% to 75%) 
Positive Predictive Value= 44% (24% to 65%) 
Negative Predictive Value= 95% (76% to 100%) 
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Table 12: Comparison of the sample with other populations 
 
Nixdorf 
2012 
Schiffman 
2010 
Fonseca-Alonso 
Odontogenic 
pain 
n=708 
TMD pain 
n=141 
Odontogenic 
pain 
n=34 
TMD pain 
n=37 
Mean (SD) or % (n) 
Age in years 48 (13) 39 (15) 49 (12) 45 (18) 
Gender: female 59 90 53 (18) 86 (32) 
Ethnicity: non-Hispanic 96 - 100 (34) 97 (36) 
Race: white 91 93 79 (27) 92 (34) 
Income ≥ $30,000 84 59* 85 (29) 43 (16) 
Level of education: 
college degree or more 
81 81 53 (18) 46 (17) 
*Income ≥$50,000 
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Table 13: DePaQ and TMD screener item analysis 
Question number: topic 
of the question 
Fischer’s 
coefficient 
Score in the 
questionnaire 
Odontogenic 
pain 
TMD pain 
Not ref. to 
teeth 
TMD pain 
Referring to 
teeth 
Min-Max Mean (SD) 
DePaQ 
Question 1: Location 7.72  0-2 1.3 (0.5) 0.2 (0.5) 1.3 (0.6) 
Question 2: Duration 3.79 1-5 2.3 (1) 4.2 (0.9) 4.2 (1.1) 
Question 3: Intensity 4.28 1-5 3 (1.2) 3.2 (1.2) 3.2 (1.1) 
Question 4: Periodicity 3.79 1-2 1.3 (0.5) 1.4 (0.5) 1.5 (0.5) 
Question 5: Radiation 0.64 1-4 2.6 (0.9) 3 (0.9) 2.8 (0.8) 
Question 6: Chewing on 
side 
1.13 1-5 4 (1) 3.2 (1.2) 3.4 (1.2) 
Question 7: Cold 
sensitivity 
3.34 1-5 3.8 (0.8) 3.4 (0.7) 3.6 (0.9) 
Question 8: Gum swelling 0.29 1-5 2 (1.2) 1.2 (0.5) 1.7 (1) 
Question 9: Loose tooth 0.23 1-4 1.2 (0.7) 1.1 (0.4) 1.4 (1) 
Question 10: Difficulty to 
swallow 
-0.72 1-5 1 (0) 1.2 (0.6) 1.7 (1) 
Question 11: Sticking out 0.05 1-5 1.6 (1.1) 1 (0) 1.3 (0.9) 
Question 12: Difficulty 
sleeping 
2.72 1-5 2.6 (1.2) 2.3 (1.4) 2.2 (1.3) 
Question 13a: Exhausting 0.03 0-1 0.3 (0.5) 0.4 (0.5) 0.7 (0.5) 
Question 13b: Electric -4.44 0-1 0.2 (0.4) 0.1 (0.3) 0.2 (0.4) 
Question 13c: Pulling -5.28 0-1 0.2 (0.4) 0.3 (0.5) 0.3 (0.5) 
Question 13d: Numb 4.88 0-1 0.3 (0.5) 0.2 (0.4) 0.3 (0.5) 
TMD screener 
Question 1: Pain duration - 0-2 1.1 (0.8) 1.4 (0.5) 1.3 (0.6) 
Question 2: Jaw stiffness - 0-1 0.3 (0.5) 0.8 (0.4) 0.9 (0.3) 
Question 3: Chewing food - 0-1 0.8 (0.4) 1 (0.2) 1 (0) 
Question 4: Opening 
mouth 
- 0-1 0.1 (0.3) 0.9 (0.3) 0.7 (0.4) 
Question 5: Clenching - 0-1 0.4 (0.5) 0.9 (0.3) 0.9 (0.3) 
Question 6: Talking - 0-1 0.1 (0.3) 0.8 (0.4) 0.4 (0.5) 
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Figures 
Figure 1: Patients enrolled 
 
SAP: Symptomatic apical periodontitis, SIP: Symptomatic irreversible pulpitis, AAA: Acute apical abscess, MFP: 
Myofascial pain.  
*Percentage from the Odontogenic pain group only. **Percentage from the TMD pain group only  
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Appendix 1: Dental Pain Questionnaire 
 
You may tick more than 1 answer in the list below 
1. Where in the mouth and/or face region do you feel the 
pain you currently have?  
tooth/teeth  
gums  
tongue  
palate  
floor of mouth  
inside of cheek  
jaw  
jaw joint  
others - please specify:     
 
 
 
Please tick only one answer for questions 2 to 12 
 Chose one word from the list below and make a tick in one box only 
2. How long have you had 
your current pain? 
less than 1 week   
1 week or longer, but less than 4 weeks  
4 weeks or longer, but less than 6 months  
6 months or longer, but less than 1 year  
1 year or longer  
 
 
 Chose one word from the list below and 
make a tick in one box only 
3. How would you describe the intensity of your current 
pain AT ITS WORST? 
Mild   
Discomforting  
Distressing  
Horrible   
Excruciating  
 
 
 Choose either episodic or continuous and 
place one tick 
4. Thinking about your current pain, how would you 
describe its pattern of occurrence? Episodic: It comes and goes  
Continuous: It’s constant  
 
  
 B 
 
 
 
 
 
 
Tick one box only 
 Not at all 
A small 
extent 
Moderate 
extent 
A large 
extent 
Complete 
extent 
5. Please indicate the extent to which your 
pain radiates to the surrounding area: 
     
 
 
 
 Tick one box only 
 
Complete 
extent 
A large 
extent 
Moderate 
extent 
A small 
extent  
Not at all  
6. Please indicate the extent to which it is 
worse when you chew or eat on the side 
of your mouth with the pain: 
     
 
 
 
 Tick one box only 
 
Makes it 
a lot 
more 
painful 
Makes it 
a little 
more 
painful 
No effect 
Makes it 
a little 
better 
Makes it 
a lot 
better 
7. Please indicate the effect of eating or 
drinking something COLD: 
     
 
 
 
 Only tick one box in each row 
Please indicate the extent to which Not at all 
A small 
extent 
Moderate 
extent 
A large 
extent 
Complete 
extent 
8. your gums have been swollen now or 
have been swollen recently: 
     
9. the tooth where you have the pain from 
feels loose: 
     
10.  it is difficult to swallow now or has been 
difficult to swallow recently: 
     
11. the tooth where you have the pain from 
feels like it is sticking out a little: 
     
 
 C 
 Tick one box only 
 
Full  
extent  
A large 
extent 
Moderate 
extent 
A small 
extent  
Not at all 
12. Please indicate the extent to which you 
have had difficulties with sleeping: 
     
 
 
 
Tick either yes or no in 
each row 
13. Which of the following word(s), if any, would you use to describe your current 
pain? 
Yes  No 
Exhausting   
Electric shocks   
Pulling   
Numb   
 
14. What other word(s), if any, would you use to describe your current pain? Please write in the space 
below:  
  
 D 
Appendix 2: TMD screener 
Question 1. In the last 30 days, on average, how long did any pain last in your jaw or 
temple area on either side? 
a) No pain 
b) From very brief to 
more than a week but it 
does stop 
c) Continuous 
   
 
 
Question 2. In the last 30 days, have you had pain or stiffness in your jaw on 
awakening? 
a) No b) Yes 
  
 
 
Questions 3-6.  
In the last 30 days, did the following activities change any pain (that is, make it better OR 
make it worse) in your jaw or temple region on either side? 
 
 
 a) No b) Yes 
3. Chewing hard or tough food   
4. Opening your mouth or moving your jaw forward or to the side   
5. Jaw habits such as holding teeth together, clenching/grinding, or 
chewing gum 
  
6. Other jaw activities such as talking, kissing, or yawning   
 
